| License: Creative Commons Attribution 4.0 PDF - Published Version (353kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-456178
- DOI to cite this document:
- 10.5283/epub.45617
Abstract
Background: Allogeneic hematopoietic stem cell transplantation (alloHSCT) is the only curative treatment modality for many patients affected by hematologic malignancies. However, it can cause debilitating long-term effects. Understanding the impact of alloHSCT on all aspects of the patients' life is required for optimal survivorship management. Aim: To explore in-depth HSCT-survivors' experiences ...
Owner only: item control page